Evaluation of some biomarkers in breast cancer patients

Proline Dehydrogenase As An Indication for Treatment Response in Sera of Patients With Breast Cancer

Serum NLRP3 and S1P as Potential Diagnostic and Prognostic Biomarkers in Female Metastatic and Non-Metastatic Breast Cancer Patients

Evaluation of the effectiveness of serum aromatase activity and tissue polypeptide specific antigen in the diagnosis of breast cancer and prediction of lymph node metastatic statu

Taurine upregulated 1: Prognostic biomarker in breast cancer

NEW MARKERS FOR BREAST CANCER

STUDY THE PROGNOSTIC VALUE OF INFLAMMATORY BLOOD MARKER FOR OVERALL SURVIVAL IN NON-METASTATIC BREAST CANCER

Importance of Serum Il-8 and Rantes as Markers for Breast Cancer Progression

UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR, PLASMINOGEN ACTIVATOR INHIBITOR- 1,EXTRACELLULAR MATRIX METALLOPROTEINASE PROTEIN INDUCER AND CA 15-3ASPOTENTIAL BIOMARKERS FOR DIAGNOSIS

Matrix Metalloproteinase-13 (MMP-13): A proposed Tumor Marker in Breast Carcinoma